Risdiplam is an orally available SMN2 pre-mRNA splicing modifier used for the treatment of spinal muscular atrophy (SMA).
Products > Drug Discovery > Inhibitor | Products > Drug Discovery > Inhibitor | Cancer | Survival Motor Neuron (SMN)
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.
日本语
한국어
Français
Deutsch
España
Türkiye